This could be a watershed moment for metabolic liver disease trials: faster, cheaper, more accurate, and better for patients
But how does a weight loss drug trigger this
Depleted intracellular glutathione has been linked to Th1/Th2 immune imbalance and increased pro-inflammatory cytokine activity, which may contribute to autoimmune thyroid disease progression (Drge, 2002)
Despite these alarming figures, obesity is a modifiable risk factor which means it can be reversed
Harrison SA, Browne SK, Suschak JJ et al (2025) Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: a randomized, double-blind, placebo-controlled study
By mimicking the GLP-1 hormone, it helps to lower hunger stimulation, ultimately leading to a reduction in food intake